PLENARY SESSION
ποΈ 22 Nov 2025
π 12:00 - 13:00
πHall A
Theme - PLENARY SESSION
Objectives - 10 mins (8 mins for presentation, 2 mins for Q&A)
A Pilot Study on Hepatitis B Core Related Antigen (HBcrAg) as a Novel Marker for Monitoring Antiviral Therapy in Chronic Hepatitis B Patients
Dr. Pravinkumar Rejliwal
12:00 - 12:10
Diagnostic Utility Of The Anastomotic:Pre-Anastomotic Portal Vein Velocity Ratio In Excluding Stenosis Following Liver Transplantation
Dr. Prajakta Jagtap
12:10 - 12:20
The 7-Point Preoperative Sfss Prediction Score: Objective Parameters To Guide Portal Inflow Modulation In Living Donor Liver Transplantation
Dr. Pradeep Kumar
12:20 - 12:30
Development And Validation Of A Prognostic Score For Predicting Outcomes In Patients Undergoing Living Donor Liver Transplantation
Dr. Vaishali Sridhar
12:30 - 12:40
Genetic And Metabolic Determinants Of Post-Transplant Graft Steatosis In Living Donor Liver Transplantation For Mash
Dr. Naren Mandalapu
12:40 - 12:50
A Study Of Plasma Metabolomics And Gut Microbiome In Non β Alcoholic Fatty Liver Disease
Dr. Anindita Phukan
12:50 - 13:00